Skip to main content

Advertisement

SpringerLink
Log in

The clinical significance and regulation mechanism of hypoxia-inducible factor-1 and miR-191 expression in pancreatic cancer

  • Research Article
  • Published:
Tumor Biology

Abstract

The aim of study was to discuss the correlation and regulatory mechanism of HIF-1 and miR-191 expression in pancreatic tumor. The association between the miR-191 and the clinicopathologic characteristics and the prognosis of pancreatic cancer was further explored. After hypoxic cultured for 6 and 12 h, qRT-PCR and Western blot were practiced to analyze the miR-191 and HIF-1 expression of MIA PaCa-2 and Aspac1 cells. We regulated the HIF-1 expression via plasmid and siRNA transfection to observe the alteration of HIF-1 and miR-191 expression. ChIP sequencing identified the binding sites of HIF-1 and miR-191. Dual luciferase assays were practiced to verify the binding sites. Immunohistochemical staining was practiced to analyze the expression of HIF-1, while qRT-PCR were done for investigating miR-191 in tumor tissues. Then, the association between the expression of them and the clinicopathologic characteristics and prognosis of pancreatic cancer were analyzed. After hypoxic cultured 12 h, the expression of HIF-1 protein, HIF-1mRNA and miR-191 of MIA PaCa-2 and AsPC-1 cells increased significantly (P < 0.05). After HIF-1 overexpressing plasmid transfected to the MIA PaCa-2 and AsPC-1 cells for 48 h, the expression of HIF-1 protein, HIF-1mRNA, and miR-191 upregulated significantly (P < 0.05). While after transfected the MIA PaCa-2 cells by HIF-1 siRNA, the significant decreasing of HIF-1 protein, HIF-1mRNA, and miR-191 expression were observed (P < 0.05). ChIP sequencing showed the protein synthesis of HIF-1 increased in hypoxia situation. Only the HRE5 (−1,169 bp, ChIP4) were significantly brighter in hypoxia in comparing with normoxic cells. In dual luciferase assays, after pGL3-miR-191 and HIF-1 overexpressing plasmid co-transfect the MIAPaCa-2 cells for 48 h, its relative expression of bioluminescence was higher than those co-transfected by mutant miR-191 vectors and HIF-1 overexpressing plasmid or by pGL3-miR-191 and HIF-1 empty plasmid. The expression of miR-191 closely associated with the tumor size, pTNM stage, lymph node metastasis, and perineural invasion (P < 0.05). Patients with higher expression of miR-191 were a risk factor for prognosis of pancreatic cancers. Expression of HIF-1 in pancreatic cancer cells increased under the condition of chronic hypoxia, which may bind to HRE2 in 5'flanking region of miR-191 and initiate transcription of miR-191. Expression of miR-191 was significantly higher in pancreatic tumor tissues. The expression of miR-191 closely associated with the tumor size, pTNM stage, lymph node metastasis and perineural invasion and poor prognosis of pancreatic cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig 1
Fig 2
Fig 3
Fig 4
Fig 5

Similar content being viewed by others

References

  1. Sun W, Julie L, Huang HD, Shyy JY, Chien S. microRNA: a master regulator of cellular processes for bioengineering systems. Annu Rev Biomed Eng. 2010;12:1–27.

    Article  CAS  PubMed  Google Scholar 

  2. Cecilia D, Simona G, Fabio M, et al. miR-210: more than a silent player in hypoxia. IUBMB Life. 2011;2(63):94–100.

    Google Scholar 

  3. Berezikov E, Furyev V, van de Belt J, Wienholds E, Plasterk RH, Cuppen E. Phylogenetic shadowing and computational identification of human microRNA genes. Cell. 2005;120(1):21–4.

    Article  CAS  PubMed  Google Scholar 

  4. Ventura A, Jacks T. MicroRNAs and cancer: short RNAs go a long way. Cell. 2009;136:586–91.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  5. Song T, Zhang X, Wang C, et al. MiR-138 suppresses expression of hypoxia-inducible factor 1α (HIF-1α) in clear cell renal cell carcinoma 786-O cells. Asian Pac J Cancer Prev. 2011;12(5):1307–11.

    PubMed  Google Scholar 

  6. Srinivas V, David L, Anders K, et al. MiRNA expression in urothelial carcinomas: important roles of miR-10a, miR-222, miR-125b, miR-7 and miR-452 for tumor stage and metastasis, and frequent homozygous losses of miR-31. Int J Cancer. 2009;124(9):2236–42.

    Article  Google Scholar 

  7. Jun Y, Kenoki O, Kazuhiro M, Jun Y, Kenoki O, Kazuhiro M, et al. MicroRNA miR-17-5p is overexpressed in pancreatic cancer, associated with a poor prognosis, and involved in cancer cell proliferation and invasion. Cancer Biol Ther. 2010;8(10):748–57.

    Google Scholar 

  8. Kizaka-Kondoh S, Tanaka S, Harada H, et al. The HIF-1-active microenvironment: an environmental target for cancer therapy. Adv Drug Deliv Rev. 2009;61(7–8):623–32.

    Article  CAS  PubMed  Google Scholar 

  9. Loscalzo J. The cellular response to hypoxia: tuning the system with microRNAs. J Clin Invest. 2010;120(11):3815–7.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  10. Stephen YC, Joseph L. MicroRNA-210 a unique and pleiotropic hypoxamir. Cell Cycle. 2010;6(9):1072–83.

    Google Scholar 

  11. Rane S et al. Downregulation of miR-199a derepresses hypoxia-inducible factor-1alpha and Sirtuin 1 and recapitulates hypoxic preconditioning in cardiac myocytes. Circ Res. 2009;104(7):879–86.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  12. Strimpakos AS, Syrigos KN, Saif MW. The molecular targets for the diagnosis and treatment of pancreatic cancer[J]. Gut Liver. 2010;12(4):433–49. doi:10.5009/gnl.2010.4.4.433.

    Article  Google Scholar 

  13. Greither T, Grochola LF, Udelnow A, et al. Elevated expression of microRNAs 155, 203, 210 and 222 in pancreatic tumors is associated with poorer survival[J]. Int J Cancer. 2010;126(1):73–80. doi:10.1002/ijc.24687.

    Article  CAS  PubMed  Google Scholar 

  14. Liu R, Chen X, Du Y, et al. Serum MicroRNA Expression Profile as a Biomarker in the Diagnosis and Prognosis of Pancreatic Cancer[J]. Clin Chem. 2012;58(3):610–8. doi:10.1373/clinchem.2011.172767.

    Article  CAS  PubMed  Google Scholar 

  15. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2- △△ Ct method[J]. Methods. 2001;25(4):402–8.

    Article  CAS  PubMed  Google Scholar 

  16. Zhao T, Gao S, Wang X, Liu J, Duan Y, et al. Hypoxia-inducible factor-1α regulates chemotactic migration of pancreatic ductal adenocarcinoma cells through directly transactivating the CX3CR1 gene. PLoS One. 2012;7(8):e43399. doi:10.1371/journal.pone.0043399.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  17. Kulshreshthar R, Ferracin M, Wojcik SE, et al. A microRNA signature of hypoxia[J]. Mol Cell Biol. 2007;27:1859–67.

    Article  Google Scholar 

  18. Garzon R, Volinia S, Liu CG, et al. MicroRNA signatures associated with cytogenetics and prognosis in acute myeloid leukemia[J]. Blood. 2008;111(6):3183–9. doi:10.1182/blood-2007-07-098749.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  19. Xi Y, Formentini A, Chien M, et al. Prognostic values of microRNAs in colorectal cancer[J]. Biomark Insights. 2006;2:113–21.

    PubMed  Google Scholar 

  20. Volinia S, Calin GA, Liu CG, et al. A microRNA expression signature of human solid tumors defines cancer gene targets[J]. Proc Natl Acad Sci. 2006;103(7):2257–61. doi:10.1073/pnas.0510565103.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  21. Calin GA, Liu CG, Sevignani C, Ferracin M, Felli N, et al. MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias[J]. Proc Natl Acad Sci. 2004;101(32):11755–60. doi:10.1073/pnas.0404432101.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  22. He Y, Cui Y, Wang W, et al. Hypomethylation of the hsa-miR-191 locus causes high expression of hsa-miR-191 and promotes the epithelial-to-mesenchymal transition in hepatocellular carcinoma[J]. Neoplasia. 2011;13(9):841–53.

    CAS  PubMed Central  PubMed  Google Scholar 

  23. Sengupta S, Kim KS, Berk MP, et al. Lysophosphatidic acid downregulates tissue inhibitor of metalloproteinases, which are negatively involved in lysophosphatidic acid-induced cell invasion[J]. Oncogene. 2007;26:2894–901.

    Article  CAS  PubMed  Google Scholar 

  24. Piper M, Barry G, Hawkins J, et al. NFIA controls telencephalic progenitor cell differentiation through repression of the Notch effector Hes1[J]. J Neurosci. 2010;30(27):9127–39. doi:10.1523/JNEUROSCI.6167-09.2010.

    Article  CAS  PubMed  Google Scholar 

  25. Starnes LM, Sorrentino A, Ferracin M, et al. A transcriptome-wide approach reveals the key contribution of NFI-A in promoting erythroid differentiation of human CD34(+) progenitors and CML cells[J]. Leukemia. 2010;24:1220–3. doi:10.1038/leu.2010.78.

    Article  CAS  PubMed  Google Scholar 

  26. Koli K, Ryynanen MJ, Keski-Oja J. Latent TGF-beta binding proteins (LTBPs)-1 and -3 coordinate proliferation and osteogenic differentiation of human mesenchymal stem cells[J]. Bone. 2008;43(4):679–88. doi:10.1016/j.bone.2008.06.016.

    Article  CAS  PubMed  Google Scholar 

  27. Chandramouli A, Simundza J, Pinderhughes A, et al. Choreographing metastasis to the tune of LTBP[J]. J Mammary Gland Biol Neoplasia. 2011;16:67–80. doi:10.1007/s10911-011-9215-3.

    Article  PubMed Central  PubMed  Google Scholar 

  28. Soutar AK. Unexpected roles for PCSK9 in lipid metabolism[J]. Curr Opin Lipidol. 2011;22(3):192–6. doi:10.1097/MOL.0b013e32834622b5.

    Article  CAS  PubMed  Google Scholar 

  29. Grentzmann G, Ingram JA, Kelly PJ, et al. A dual-luciferase reporter system for studying recoding signals[J]. RNA. 1998;4(4):479–86.

    CAS  PubMed Central  PubMed  Google Scholar 

  30. Shi X, Su S, Long J, et al. MicroRNA-191 targets N-deacetylase/N-sulfotransferase 1 and promotes cell growth in human gastric carcinoma cell line MGC803[J]. Acta Biochim Biophys Sin. 2011;43(11):849–56. doi:10.1093/abbs/gmr084.

    Article  CAS  PubMed  Google Scholar 

  31. Elyakim E, Sitbon E, Faerman A, et al. hsa- miR-191 is a candidate oncogene target for hepatocellular carcinoma therapy[J]. Cancer Res. 2010;70:8077–87. doi:10.1158/0008-5472.CAN-10-1313.

    Article  CAS  PubMed  Google Scholar 

  32. Di Leva GD, Piovan C, Gasparini P, et al. Estrogen mediated-activation of miR-191/425 cluster modulates tumorigenicity of breast cancer cells depending on estrogen receptor status[EB/OL]. PLoS Genet. 2013;9(3):e1003311. doi:10.1371/journal.pgen.1003311.

    Article  PubMed Central  PubMed  Google Scholar 

  33. Caramuta S, Egyhazi S, Rodolfo M, et al. MicroRNA expression profiles associated with mutational status and survival in malignant melanoma[J]. J Investig Dermatol. 2010;130:2062–70. doi:10.1038/jid.2010.63.

    Article  CAS  PubMed  Google Scholar 

  34. Hui AB, Shi W, Boutros PC, et al. Robust global micro-RNA profiling with formalin-fixed paraffin-embedded breast cancer tissues[J]. Lab Investig. 2009;89:597–606. doi:10.1038/labinvest.2009.12.

    Article  CAS  PubMed  Google Scholar 

  35. Shen J, DiCioccio R, Odunsi K, et al. Novel genetic variants in miR-191 gene and familial ovarian cancer[J]. BMC Cancer. 2010;10:47–56. doi:10.1186/1471-2407-10-47.

    Article  PubMed Central  PubMed  Google Scholar 

  36. Wynendaele J, Bohnke A, Leucci E, et al. An illegitimate microRNA target site within the 3′ UTR of MDM4 affects ovarian cancer progression and chemosensitivity[J]. Cancer Res. 2010;70:9641–9. doi:10.1158/0008-5472.CAN-10-0527.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pancreatic Cancer, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, China

    Zhenguo Song, He Ren, Song Gao, Xiao Zhao, Huan Zhang & Jihui Hao

  2. Department of Anesthesiology and Operating Center, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy , Tianjin, China

    Zhenguo Song

Authors
  1. Zhenguo Song
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. He Ren
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Song Gao
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Xiao Zhao
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Huan Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Jihui Hao
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Zhenguo Song.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Song, Z., Ren, H., Gao, S. et al. The clinical significance and regulation mechanism of hypoxia-inducible factor-1 and miR-191 expression in pancreatic cancer. Tumor Biol. 35, 11319–11328 (2014). https://doi.org/10.1007/s13277-014-2452-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13277-014-2452-5

Keywords

Search

Navigation